Cargando…
Antimicrobial Drug Prescribing for Pneumonia in Ambulatory Care
To determine patterns and predictors of antimicrobial drug use for outpatients with community-acquired pneumonia, we examined office visit and pharmacy claims data of 4 large third-party payer organizations from 2000 to 2002. After patients with coexisting conditions were excluded, 4,538 patients we...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298265/ https://www.ncbi.nlm.nih.gov/pubmed/15757551 http://dx.doi.org/10.3201/eid1103.040819 |
_version_ | 1782225970187468800 |
---|---|
author | MacDougall, Conan Guglielmo, B. Joseph Maselli, Judy Gonzales, Ralph |
author_facet | MacDougall, Conan Guglielmo, B. Joseph Maselli, Judy Gonzales, Ralph |
author_sort | MacDougall, Conan |
collection | PubMed |
description | To determine patterns and predictors of antimicrobial drug use for outpatients with community-acquired pneumonia, we examined office visit and pharmacy claims data of 4 large third-party payer organizations from 2000 to 2002. After patients with coexisting conditions were excluded, 4,538 patients were studied. Despite lack of coexisting conditions, fluoroquinolone use was commonly observed and increased significantly (p < 0.001) from 2000 to 2002 (24%–39%), while macrolide use decreased (55%–44%). Increased age correlated with increased fluoroquinolone use: 18–44 years (22%), 45–64 years (33%), and >65 years (40%) (p < 0.001). Increased use of fluoroquinolones occurred in healthy young and old patients alike, which suggests a lack of selectivity in reserving fluoroquinolones for higher risk patients. Clear and consistent guidelines are needed to address the role of fluoroquinolones in treatment of outpatient community-acquired pneumonia. |
format | Online Article Text |
id | pubmed-3298265 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-32982652012-03-12 Antimicrobial Drug Prescribing for Pneumonia in Ambulatory Care MacDougall, Conan Guglielmo, B. Joseph Maselli, Judy Gonzales, Ralph Emerg Infect Dis Research To determine patterns and predictors of antimicrobial drug use for outpatients with community-acquired pneumonia, we examined office visit and pharmacy claims data of 4 large third-party payer organizations from 2000 to 2002. After patients with coexisting conditions were excluded, 4,538 patients were studied. Despite lack of coexisting conditions, fluoroquinolone use was commonly observed and increased significantly (p < 0.001) from 2000 to 2002 (24%–39%), while macrolide use decreased (55%–44%). Increased age correlated with increased fluoroquinolone use: 18–44 years (22%), 45–64 years (33%), and >65 years (40%) (p < 0.001). Increased use of fluoroquinolones occurred in healthy young and old patients alike, which suggests a lack of selectivity in reserving fluoroquinolones for higher risk patients. Clear and consistent guidelines are needed to address the role of fluoroquinolones in treatment of outpatient community-acquired pneumonia. Centers for Disease Control and Prevention 2005-03 /pmc/articles/PMC3298265/ /pubmed/15757551 http://dx.doi.org/10.3201/eid1103.040819 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research MacDougall, Conan Guglielmo, B. Joseph Maselli, Judy Gonzales, Ralph Antimicrobial Drug Prescribing for Pneumonia in Ambulatory Care |
title | Antimicrobial Drug Prescribing for Pneumonia in Ambulatory Care |
title_full | Antimicrobial Drug Prescribing for Pneumonia in Ambulatory Care |
title_fullStr | Antimicrobial Drug Prescribing for Pneumonia in Ambulatory Care |
title_full_unstemmed | Antimicrobial Drug Prescribing for Pneumonia in Ambulatory Care |
title_short | Antimicrobial Drug Prescribing for Pneumonia in Ambulatory Care |
title_sort | antimicrobial drug prescribing for pneumonia in ambulatory care |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298265/ https://www.ncbi.nlm.nih.gov/pubmed/15757551 http://dx.doi.org/10.3201/eid1103.040819 |
work_keys_str_mv | AT macdougallconan antimicrobialdrugprescribingforpneumoniainambulatorycare AT guglielmobjoseph antimicrobialdrugprescribingforpneumoniainambulatorycare AT masellijudy antimicrobialdrugprescribingforpneumoniainambulatorycare AT gonzalesralph antimicrobialdrugprescribingforpneumoniainambulatorycare |